Search | Médecins Sans Frontières Access Campaign

Search results for: ACTA

30 results found
There are 0 active filters

30 results found

Issue brief |

21 December 2021

COVAX: A broken promise to the world

Analysis of the COVAX Facility and the need for radical change in making COVID-19 vaccines accessible to the world

Tags COVID-19 coronavirus World Health Organization covid medical tools access

Press release |

21 July 2021

Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug

Following a breakthrough in treatment of HIV-related cryptococcal meningitis, MSF urges Gilead to immediately scale up access to lifesaving drug L-AmB

Tags HIV/AIDS cryptococcal meningitis liposomal amphotericin B World Health OrganizationGilead

Letter |

23 June 2021

Open letter to WHO & ACT-A: We need affordable treatments for the rise of serious invasive fungal diseases that are life-threatening for COVID-19 survivors and HIV+ people

Open letter sent to WHO and ACT-A calling for access to liposomal amphotericin B (L-AmB) to treat mucormycosis (black fungus) and other diseases

Tags Tropical & neglected diseases mucormycosiscryptococcal meningitis liposomal amphotericin B World Health OrganizationGilead

Press release |

22 June 2021

Ahead of Gavi’s board meeting, MSF urges critical look at COVAX shortcomings

As the Gavi board meets this week (23-24th June 2021), one topic on their agenda will be changes to the COVAX Facility. As the global health community increasingly discusses models to be prepared for future pandemics, MSF cautions that ...

Tags COVID-19 coronavirus

MSF International President, Dr. Christos Christou, visited our COVID-19 emergency projects in Rondônia, Brazil.

Press release |

10 June 2021

MSF statement on G7 summit discussions on pandemic response

It’s precisely the actions of the G7 governments, among others, that have led to the grave global inequities we see in access to COVID-19 medical tools now, despite several of these leaders having stated early on that such tools should ...

Tags COVID-19 coronavirus

Statement |

15 December 2020

Statement to the WIPO 32nd Session of the Standing Committee on the Law of Patents

Médecins Sans Frontières (MSF) welcomes the SCP to continue the discussion of the agenda item Patents and Health. It is a critical time for WIPO members to closely examine the implication of patent law on access to medicines in the ...

Tags COVID-19 coronavirus TRIPS World Health Organization covid medical tools access

covid_southafrica_treatmentfacility_rowan_pybus_2020_msf322133_3800px

Statement |

05 October 2020

MSF Statement for WHO Executive Board Special Session on COVID-19 Response

On October 5, 2020, MSF submitted this statement as a non-state actor to the WHO Special Session of the Executive Board on the implementation of resolution WHA73.1, regarding global COVID-19 response. MSF urged WHO and its member ...

Tags COVID-19 coronavirus covid medical tools access

Technical brief |

21 July 2020

Achieving equitable global access resulting from the ACT Accelerator

In this briefing document, MSF, the European Alliance for Responsible R&D and Affordable Medicines, and several other civil society organisations (CSOs) set out the principles and practices that should be implemented within ACT-A to ...

Tags COVID-19 coronavirus covid medical tools access

Press release |

01 July 2019

MSF update on 26th round of RCEP negotiations in Melbourne, Australia

While we welcome the recent withdrawal of harmful provisions from the IP chapter of RCEP, namely patent term extensions and data exclusivity, Japan’s strong push for elevated IP enforcement measures continues to be a matter of grave ...

Tags Intellectual property and trade generic medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) India